FDA.reportPublic FDA data

DIDANOSINE

Substance profile for UNII K3GDH6OH08, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for DIDANOSINE
Structure render from PubChem CID 50599

Substance Identity#

UNII
K3GDH6OH08
Preferred term
DIDANOSINE
Registry number
69655-05-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C10H12N4O3
Chemical structure for DIDANOSINE
Structure render from PubChem CID 50599

Chemical And Database Identifiers#

InChIKey
BXZVVICBKDXVGW-NKWVEPMBSA-N
SMILES
OC[C@@H]1CC[C@@H](O1)N2C=NC3=C2N=CNC3=O
RxCUI
3364
PubChem
50599
NCIt
C431
INN ID
6664

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound50599https://pubchem.ncbi.nlm.nih.gov/compound/50599
PubChem InChIKey SearchBXZVVICBKDXVGW-NKWVEPMBSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=BXZVVICBKDXVGW-NKWVEPMBSA-N
RxNorm3364https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=3364
NCI ThesaurusC431https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C431
FDA Substance Registration SystemK3GDH6OH08https://precision.fda.gov/uniisearch/srs/unii/K3GDH6OH08

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DIDANOSINEACTIVE INGREDIENTK3GDH6OH08These highlights do not include all the information needed to use didanosine delayed-release capsules safely and effectively. See full prescribing information for didanosine delayed-release capsules. Initial U.S. Approval: 19911
DIDANOSINEACTIVE MOIETYK3GDH6OH08These highlights do not include all the information needed to use didanosine delayed-release capsules safely and effectively. See full prescribing information for didanosine delayed-release capsules. Initial U.S. Approval: 19911
DIDANOSINEACTIVE MOIETYK3GDH6OH08These highlights do not include all the information needed to use Didanosine Delayed-Release Capsules Enteric-Coated Pellets safely and effectively. See full prescribing information for Didanosine Delayed-Release Capsules Enteric-Coated Pellets. Initial U.S. Approval: 19912
DIDANOSINEACTIVE INGREDIENTK3GDH6OH08These highlights do not include all the information needed to use Didanosine Delayed-Release Capsules Enteric-Coated Pellets safely and effectively. See full prescribing information for Didanosine Delayed-Release Capsules Enteric-Coated Pellets. Initial U.S. Approval: 19912
didanosineACTIVE INGREDIENTK3GDH6OH08VIDEX (DIDANOSINE) POWDER, FOR SOLUTION [BRISTOL-MYERS SQUIBB COMPANY]16
didanosineACTIVE MOIETYK3GDH6OH08VIDEX (DIDANOSINE) POWDER, FOR SOLUTION [BRISTOL-MYERS SQUIBB COMPANY]16
didanosineACTIVE MOIETYK3GDH6OH08VIDEX EC (DIDANOSINE) CAPSULE, DELAYED RELEASE [BRISTOL-MYERS SQUIBB COMPANY]13
didanosineACTIVE INGREDIENTK3GDH6OH08VIDEX EC (DIDANOSINE) CAPSULE, DELAYED RELEASE [BRISTOL-MYERS SQUIBB COMPANY]13
DIDANOSINEACTIVE INGREDIENTK3GDH6OH08DIDANOSINE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED]8
DIDANOSINEACTIVE MOIETYK3GDH6OH08DIDANOSINE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED]8
DIDANOSINEACTIVE INGREDIENTK3GDH6OH08DIDANOSINE CAPSULE, DELAYED RELEASE PELLETS [BARR LABORATORIES INC.]8
DIDANOSINEACTIVE MOIETYK3GDH6OH08DIDANOSINE CAPSULE, DELAYED RELEASE PELLETS [BARR LABORATORIES INC.]8
DIDANOSINEACTIVE MOIETYK3GDH6OH08DIDANOSINE (DIDANOSINE ENTERIC-COATED BEADLETS) CAPSULE, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.]5
DidanosineACTIVE INGREDIENTK3GDH6OH08DIDANOSINE (DIDANOSINE ENTERIC-COATED BEADLETS) CAPSULE, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.]5